Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Perioperative INGN 201 Gene Therapy and Chemoradiotherapy for Advanced Head and Neck Cancer
NCT00017173Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2003
- Primary completion
- May 2007
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Ad5CMV-p53 in head and neck squamous cell carcinoma (HNSCC), sponsored by SWOG Cancer Research Network. Primary endpoint: Feasibility at 1 year. Started Feb 2003; status: terminated.
02
Drugs
Ad5CMV-p53
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00017173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017173.